Blockdaemon, the leading U.S. headquartered institutional-grade crypto infrastructure company, announced today the appointment of Alex Zinder as Chief Product Officer (CPO). In this role, Zinder will lead overall product development, sharpen product vision, strengthen execution rhythm, and elevate Blockdaemon's platform offerings which include staking, DeFi, MPC wallets and vaults, nodes, and APIs. https://mma.prnewswire.com/media/2714566/Blockdaemon_Primary_Purple_Logo.jpg With over […]

(NYSE MKT:CMCL),(LSE – AIM:CMCL),(LSE:CMCL.L),(LSE:CMCL.LN), ST HELIER, Jersey, July 02, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that it received notification on June 30, 2025 from BlackRock, Inc. that on June 27, 2025 it had crossed a threshold for notification of a relevant

(Euronext Amsterdam:SHELL),(LSE:SHEL),(NYSE:SHEL), Due to EY non-compliance with audit partner rotation rules, Shell to update 2023 and 2024 Form 20-Fs; financial statements remain unchanged London, July 2, 2025 – Ernst & Young LLP (“EY”) has advised Shell plc that, for the years ended December 31, 2023 and 2024, EY was not in compliance with the SEC

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both Type 2 diabetic patients and healthy volunteers Magnetohydrodynamic (MHD) technology achieves 11.5% MARD in extensive clinical performance study using mass-manufactured devices, validating commercial-scale production capability Helsinki, Finland – July 2, 2025

(Paris:OSE), OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that following the hearing on June 24th, 2025, the President of the Nantes Commercial Court rejected, pursuant to an order dated July 1, 2025, the motions brought by the group

Due to EY non-compliance with audit partner rotation rules, Shell to update 2023 and 2024 Form 20-Fs; financial statements remain unchanged GlobeNewswire July 02, 2025 Due to EY non-compliance with audit partner rotation rules, Shell to update 2023 and 2024 Form 20-Fs; financial statements remain unchanged London, July 2, 2025 – Ernst & Young LLP

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch GlobeNewswire July 02, 2025 GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both Type 2 diabetic patients and healthy volunteers Magnetohydrodynamic (MHD) technology achieves 11.5% MARD

OSE Immunotherapeutics met a jour l'information sur les procedures en cours GlobeNewswire July 02, 2025 OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that following the hearing on June 24th, 2025, the President of the Nantes Commercial Court rejected,

Caledonia Mining Corporation Plc Notification of relevant change to significant shareholder GlobeNewswire July 02, 2025 ST HELIER, Jersey, July 02, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that it received notification on June 30, 2025 from BlackRock, Inc. that on June 27,

Center stage, a spotlight slowly descends, illuminating the figure of “Jiao Yulu.” Portrayed by Niu Haozhe, a young teacher, “Jiao” stands in faded, worn clothing, his deep gaze fixed on the audience below. “Who are you?… It's 2025? What will that look like? Will everyone be able to eat steamed buns made from fine flour?